MedPage Today (5/5, George) reports, “Older adults in the U.S. were less likely to develop dementia if they received the recombinant subunit zoster (shingles) vaccine (Shingrix), an analysis of 1.5 million Medicare beneficiaries showed.” Investigators found that “the incidence of any type of dementia was 10.45 (95% CI 10.29-10.62) per 1,000 person-years for older adults who received the two-dose shingles vaccine and 15.73 (95% CI 15.57-15.89) per 1,000 person-years for contemporary comparators who were unvaccinated.” The findings were published in Alzheimer’s & Dementia.
Related Links:
— MedPage Today (requires login and subscription)